August 15, 2024CorporateTerumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish PlatformNew publication confirms the ability of Terumo BCT’s FINIA™ Fill and Finish System to automate large volumes across multiple autologous and allogeneic cell and gene therapy workflows.
August 02, 2024FinancialNotice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 114.6 KB)